AIM: To investigate the effect of rs35100176 CCT insertion/deletion polymorphism in the promoter region of importin 8 (IPO8) gene on its mRNA expression. METHODS: A 342-bp fragment of IPO8 gene promoter containing the rs35100176 polymorphism was amplified from 49 DNA samples and sequenced. The IPO8 promoter fragments containing CCT 3-nucleotide insertion or deletion were amplified using the corresponding homozygote DNA samples. The PCR products were sequenced and inserted into the luciferase reporter vector pGL3-Basic. Recombinant vectors were transfected into the cells by Fugene 6.0 and the expression of the reporter gene was detected by a dual-luciferase reporter assay system. The mRNA expression level of IPO8 was detected by real-time PCR in 3-nucleotide insertion or deletion homozygote cells. RESULTS:The sequencing results showed that there were 3 kinds of genotypes in the rs35100176 polymorphism, CCT/CCT,CCT/- and -/-, and the gene frequencies were 1837%, 5510% and 2653%, respectively. The recombinant expression vectors pGL3-3N Insertion and pGL3-3N Deletion were successfully constructed. The luciferase assay showed that pGL3-3N Insertion produced significantly lower luciferase activity than that by pGL3-3N Deletion. Real-time PCR showed that HEK293 cells with 3-nucleotide insertion homozygote expressed relative lower IPO8 mRNA than Saos-2 cells with 3-nucleotide deletion homozygote. CONCLUSION:The CCT 3-nucleotide insertion variant decreases the promoter activity of IPO8, thus affecting the gene expression.
Gorlich D, Dabrowski M, Bischoff FR, et al. A novel class of RanGTP binding proteins[J]. J Cell Biol, 1997, 138(1):65-80.
[2]
Hurtado del Pozo C, Calvo RM, Vesperinas-Garcia G, et al. IPO8 and FBXL10: new reference genes for gene expression studies in human adipose tissue[J]. Obesity (Silver Spring), 2010, 18(5):897-903.
[3]
Kreth S, Heyn J, Grau S, et al. Identification of valid endogenous control genes for determining gene expression in human glioma[J]. Neuro Oncol, 2010, 12(6):570-579.
[4]
Weinmann L, Hock J, Ivacevic T, et al. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs[J]. Cell, 2009, 136(3):496-507.
Xiong J, Che X, Li X, et al. Cloning and characterization of the human USP22 gene promoter[J]. PLoS One, 2012, 7(12):e52716.
[7]
Cook A, Bono F, Jinek M, et al. Structural biology of nucleocytoplasmic transport[J]. Annu Rev Biochem, 2007, 76:647-671.
[8]
Nguewa PA, Agorreta J, Blanco D, et al. Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens[J]. BMC Mol Biol, 2008, 9:103.
[9]
Liu J, Carmell MA, Rivas FV, et al. Argonaute2 is the catalytic engine of mammalian RNAi[J]. Science, 2004, 305(5689):1437-1441.
Kearns AE, Goto K, Gianakakos G, et al. Transcriptional repression of the rat osteocalcin gene: role of two intronic CCTCCT motifs[J]. Endocrinology, 1999, 140(9):4120-4126.
[12]
Tone M, Tone Y, Babik JM, et al. The role of Sp1 and NF-κB in regulating CD40 gene expression[J]. J Biol Chem, 2002, 277(11):8890-8897.
[13]
Sooy K, Demay MB. Transcriptional repression of the rat osteocalcin gene by δEF1[J]. Endocrinology, 2002, 143(9):3370-3375.